- Home
- FRSH vs ACLX Comparison
FRSH vs ACLX Comparison
Compare FRSH & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSH
- ACLX
- Stock Information
- Founded
- FRSH 2010
- ACLX 2015
- Country
- FRSH United States
- ACLX United States
- Employees
- FRSH N/A
- ACLX N/A
- Industry
- FRSH EDP Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- FRSH Technology
- ACLX Health Care
- Exchange
- FRSH Nasdaq
- ACLX Nasdaq
- Market Cap
- FRSH 3.9B
- ACLX 4.1B
- IPO Year
- FRSH 2021
- ACLX 2022
- Fundamental
- Price
- FRSH $12.72
- ACLX $76.42
- Analyst Decision
- FRSH Buy
- ACLX Strong Buy
- Analyst Count
- FRSH 15
- ACLX 13
- Target Price
- FRSH $20.13
- ACLX $114.75
- AVG Volume (30 Days)
- FRSH 3.8M
- ACLX 507.4K
- Earning Date
- FRSH 11-05-2025
- ACLX 11-06-2025
- Dividend Yield
- FRSH N/A
- ACLX N/A
- EPS Growth
- FRSH N/A
- ACLX N/A
- EPS
- FRSH N/A
- ACLX N/A
- Revenue
- FRSH $782,097,000.00
- ACLX $56,979,000.00
- Revenue This Year
- FRSH $17.03
- ACLX N/A
- Revenue Next Year
- FRSH $12.97
- ACLX $174.18
- P/E Ratio
- FRSH N/A
- ACLX N/A
- Revenue Growth
- FRSH 19.78
- ACLX N/A
- 52 Week Low
- FRSH $10.81
- ACLX $47.86
- 52 Week High
- FRSH $19.77
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- FRSH 43.17
- ACLX 61.10
- Support Level
- FRSH $12.33
- ACLX $73.16
- Resistance Level
- FRSH $13.49
- ACLX $78.61
- Average True Range (ATR)
- FRSH 0.44
- ACLX 2.84
- MACD
- FRSH -0.04
- ACLX 0.55
- Stochastic Oscillator
- FRSH 26.15
- ACLX 75.42
About FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.